dc.contributor.author | UNLUER, E | |
dc.contributor.author | AMASYALI, Akın Soner | |
dc.contributor.author | YAZICI, M | |
dc.contributor.author | TASCI, Ayşe Çağlar | |
dc.contributor.author | Citgez, SİNHARİB | |
dc.contributor.author | KOCAN, H | |
dc.contributor.author | YUCETAS, U | |
dc.contributor.author | YUCETAS, E | |
dc.date.accessioned | 2021-03-05T20:44:20Z | |
dc.date.available | 2021-03-05T20:44:20Z | |
dc.identifier.citation | KOCAN H., Citgez S., YUCETAS U., YUCETAS E., YAZICI M., AMASYALI A. S. , UNLUER E., TASCI A. Ç. , "Can ischemia-modified albumin be used as an objective biomarker for renal ischemic damage? An experimental study with Wistar albino rats.", Transplantation proceedings, cilt.46, ss.3326-9, 2014 | |
dc.identifier.issn | 0041-1345 | |
dc.identifier.other | vv_1032021 | |
dc.identifier.other | av_d59e603e-069a-4372-836e-84e418079b94 | |
dc.identifier.uri | http://hdl.handle.net/20.500.12627/140949 | |
dc.identifier.uri | https://doi.org/10.1016/j.transproceed.2014.11.001 | |
dc.language.iso | eng | |
dc.title | Can ischemia-modified albumin be used as an objective biomarker for renal ischemic damage? An experimental study with Wistar albino rats. | |
dc.type | Makale | |
dc.relation.journal | Transplantation proceedings | |
dc.contributor.department | Sağlık Bilimleri Üniversitesi , , | |
dc.identifier.volume | 46 | |
dc.identifier.startpage | 3326 | |
dc.identifier.endpage | 9 | |
dc.contributor.firstauthorID | 160720 | |